THE ROLE OF CL. WELCHII TYPE A IN EXPERIMENTAL INTESTINAL OBSTRUCTION.
D000818:Animals; D000992:Antitoxins; D001407:Bacillus; D001439:Bacteroides; D003013:Clostridium; D003016:Clostridium perfringens; D004285:Dogs; D004755:Enterobacteriaceae; D013293:Enterococcus faecalis; D004926:Escherichia coli; D007415:Intestinal Obstruction; D007709:Klebsiella; D008837:Micrococcus; D009355:Neomycin; D010336:Pathology; D010406:Penicillins; D010600:Pharmacology; D011511:Proteus; D011549:Pseudomonas; D012106:Research; D012505:Sarcina; D013210:Staphylococcus; D013291:Streptococcus; D014118:Toxins, Biological; D014357:Trypsin
D000992:Antitoxins; D010406:Penicillins; D014118:Toxins, Biological; D014357:Trypsin; D009355:Neomycin
BACILLUS; BACTEROIDES; CLOSTRIDIUM; CLOSTRIDIUM PERFRINGENS; DOGS; ESCHERICHIA COLI; EXPERIMENTAL LAB STUDY; INTESTINAL OBSTRUCTION; KLEBSIELLA; MICROCOCCUS; NEOMYCIN; PARACOLOBACTRUM; PATHOLOGY; PENICILLIN; PHARMACOLOGY; PROTEUS; PSEUDOMONAS; SARCINA; STAPHYLOCOCCUS; STREPTOCOCCUS; STREPTOCOCCUS FAECALIS; TOXINS AND ANTITOXINS; TRYPSIN